Hemofarm a.d.
ヘモファーム a.d.は、輸出対応の B2B チャネル向けにジェネリック医薬品を製造しています。
ヘモファーム a.d. Vrsac でジェネリック医薬品、無菌製品、および医薬品製剤を製造しています。 1960 年に設立された同社は、薬局、病院、ヘルスケア販売業者、RS、BA、MK、DE および関連する輸出市場に製品を供給しています。
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Vrsac, Serbia
- Founded
- 1960
- Website
- hemofarm.com
- Categories
- 医療およびヘルスケア用品
- Markets
- セルビア, ボスニア・ヘルツェゴビナ, 北マケドニア, ドイツ
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- registered-manufacturer (green), checked 2026-08-21 ALIMS (Medicines and Medical Devices Agency of Serbia), register of medical-device manufacturers
- product-authorised-for-sale (green), checked 2026-08-21 Ministry of Health of Armenia, State Register of Medicinal Products (pharm.am)
- sanctions-clear (green), checked 2026-08-12 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- debarment-clear (green), checked 2026-08-12 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- domain-registered (green), checked 2026-08-12 Domain registry record
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)